Loading cancer entity…
Loading cancer entity…
Clinical trials
79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03193437 | Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy(SELECT) | terminated | Phase 2 | 8 | Georgetown UniversityOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT02062632 | Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy | terminated | Phase 2 | 5 | Mayo ClinicOTHER | 1 | Oct 1, 2019 |
| clinicaltrials |
| NCT01301391 | Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy | terminated | Phase 2 | 30 | Tiziana Life Sciences LTDINDUSTRY | 2 | Feb 6, 2019 | clinicaltrials |
| NCT01100944 | A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies | terminated | Phase 1 / Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Aug 10, 2017 | clinicaltrials |
| NCT00718809 | Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer | terminated | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jun 10, 2015 | clinicaltrials |
| NCT00818090 | Paclitaxel and Cisplatin for Thymic Neoplasm | terminated | Phase 2 | 39 | Korean Cancer Study GroupOTHER | 1 | Apr 12, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Feb 16, 2023source: clinicaltrials